Article
Innate immunity pathways regulate the nephropathy gene Apolipoprotein L1.
Kidney international - 1 Feb 2015
Nichols Brendan, Jog Prachi, Lee Jessica H, Blackler Daniel, Wilmot Michael, D'Agati Vivette, Markowitz Glen, Kopp Jeffrey B, Alper Seth L, Pollak Martin R, Friedman David J
Abstract excerpt
Apolipoprotein L1 (APOL1) risk variants greatly elevate the risk of kidney disease in African Americans. Here we report a cohort of patients who developed collapsing focal segmental glomerulosclerosis while receiving therapeutic interferon, all of whom carried the APOL1 high-risk genotype. This finding raised the possibility that interferons and the molecular pattern recognition receptors that stimulate...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
